4523 On Other Exchanges
4523 is not on other exchanges.

Executive Profile*

Gary Hendler

Chief Commercial Officer-Oncology Business, SVP, President-EMEA & Eisai Global Oncology Business,Eisai Co., Ltd.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

As of Fiscal Year 2017


Gary Hendler serves as Chief Commercial Officer of Oncology Business Group at Eisai Inc. Gary Hendler serves as Senior Vice President at Eisai Co., Ltd. Gary Hendler serves as Chief Executive Officer of Eisai Europe Ltd, President of Eisai Europe Ltd, President of EMEA Region and President of Eisai Global Oncology Business Unit. Gary Hendler served as Vice President of Eisai Co. Ltd. since June 18, 2010 and serves as its President of EMEA Region. Gary Hendler serves ...

Read Full Background


Corporate Headquarters*

4-6-10, Koishikawa
Tokyo, -- 112-8088


Phone: 81 3 3817 3016
Fax: 81 3 3811 6032

Board Members Memberships*

There is no Board Members Memberships data available.


There is no Education data available.

Other Affiliations*

Annual Compensation*

Total Annual Compensation¥111,000,000

Stock Options*

Long Term Incentive Plan¥15,000,000

Total Compensation*

Total Annual Cash Compensation¥111,000,000
Total Short Term Compensation¥111,000,000
Total Calculated Compensation¥126,000,000
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Jeffrey Marc Leiden Chairman, CEO & President
Vertex Pharmaceuticals Incorporated
David D. Meek CEO & Director
Ipsen S.A.
Hervé Hoppenot Chairman of the Board, President & CEO
Incyte Corporation
Bruce C. Cozadd Co-Founder, Executive Chairman & CEO
Jazz Pharmaceuticals plc
Sigurdur Oli Olafsson Ph.D.CEO & Executive Director
Hikma Pharmaceuticals PLC
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact EISAI CO LTD, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.